| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 202340-45-2 | Eflucimibe |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 2 | 1268244-88-7 | Px-104 |
≥98% | | 询价 |
| 3 | 164025-33-6 | PWZ-029 |
≥98% | | 询价 |
| 4 | 81047-99-6 | CGP 12177 hydrochloride |
≥98% | | 询价 |
| 5 | 1093793-10-2 | PV-1115 |
≥98% | | 询价 |
| 6 | 632-69-9 | PV-10 sodium |
≥98% | | 询价 |
| 7 | 139543-40-1 | LY 202769 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 8 | 111112-18-6 | LY 195448 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 9 | 122620-17-1 | LY 193239 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 10 | 146117-78-4 | LY 191704 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 11 | 126165-79-5 | LY 186826 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 12 | 103828-81-5 | LY 207702 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 13 | 412961-36-5 | BAM8-22 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 14 | 105496-35-3 | LY 190388 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 15 | 143982-31-4 | LY 186564 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 16 | 114943-19-0 | LY 178210 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 17 | 102993-90-8 | LY 183648 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 18 | 3955-50-8 | LY 181984 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 19 | 100644-00-6 | LY 186126 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 20 | 141318-62-9 | LY 293284 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 21 | 153034-77-6 | LY 292728 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 22 | 146554-87-2 | LY 290324 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 23 | 148314-61-8 | LY 289612 |
≥98% | | 询价 |
| 24 | 152920-47-3 | LY 288601 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 25 | 105027-75-6 | LY 281217 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 26 | 153226-99-4 | LY 280748 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 27 | 119193-37-2 | LY 278584 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 28 | 136109-04-1 | LY 274614 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 29 | 132392-65-5 | LY 269415 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 30 | 150010-68-7 | LY 215490 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 31 | 117423-95-7 | LY 213024 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 32 | | Tetrazanbigen |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 33 | | Myricetin sodium |
≥98% | | 询价 |
| 34 | 122009-61-4 | LY 203647 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 35 | 109306-94-7 | LY 201409 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 36 | 1454619-14-7 | PU-WS13 |
≥98% | | 询价 |
| 37 | 212844-54-7 | Purvalanol B(NG 95) |
≥98% | | 询价 |
| 38 | 64519-82-0 | Palatinit |
≥98% | | 询价 |
| 39 | 19855-39-1 | Purpurea glycoside B |
≥98% | | 询价 |
| 40 | 19855-40-4 | Purpurea glycoside A |
≥98% | | 询价 |
| 41 | 148408-65-5 | Sunepitron HCl |
≥98% | | 询价 |
| 42 | 146389-61-9 | Zaragozic acid B |
≥98% | | 询价 |
| 43 | | Puromycin hydrochloride |
≥98% | | 询价 |
| 44 | 53-79-2 | Puromycin(CL13900) |
≥98% | | 询价 |
| 45 | 102734-12-3 | Punctaporonin D |
≥98% | | 询价 |
| 46 | 14439-61-3 | RO5-4864 |
≥98% | | 询价 |
| 47 | 158364-59-1 | Pumaprazole |
≥98% | | 询价 |
| 48 | 207993-12-2 | Pumafentrine |
≥98% | | 询价 |
| 49 | 149128-48-3 | Pentapeptide-4 |
≥98% | | 询价 |
| 50 | 89-82-7 | Pulegone |
≥98% | | 询价 |
| 51 | 1202865-65-3 | PU-H71 hydrate(NSC-750424) |
≥98% | | 询价 |
| 52 | 852030-37-6 | PU-H54-iso |
≥98% | | 询价 |
| 53 | 352519-21-2 | PU3 |
≥98% | | 询价 |
| 54 | 422508-46-1 | PU24FCl |
≥98% | | 询价 |
| 55 | 856681-05-5 | Lorcaserin HCl hemihydrate |
≥98% | | 询价 |
| 56 | 422508-29-0 | PU-20F |
≥98% | | 询价 |
| 57 | 168334-34-7 | PU141 |
≥98% | | 询价 |
| 58 | 158093-65-3 | PU139 |
≥98% | | 询价 |
| 59 | 1454619-18-1 | PU-11 |
≥98% | | 询价 |
| 60 | 92218-37-6 | LY 164846 |
≥98% | 50mg, 100mg, 250mg | 询价 |
m.cnreagent.com